Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Rigel to Participate in Three Upcoming Investor Conferences
-
UPDATE: Cantor Fitzgerald Starts Regulus Therapeutics (RGLS) at Overweight
-
DTRT Health Acquisition Corp. (DTRTU) Prices 20M Unit IPO at $10/unit
-
Insight Acquisition Corp (INAQ.U) Prices 24M Unit IPO at $10/unit
-
Ascendis Pharma (ASND) Prices 2.5M ADS Offering at $160/sh
-
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
-
Insight Acquisition Corp. Announces Pricing of $240 Million Initial Public Offering
-
DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Aug 31
-
Nickel 28 Capital Corp (NKL:CN) (CONXF) PT Lowered to Cdn$1.80 at Cantor Fitzgerald
-
Insmed To Participate in Five September Conferences
-
Akebia Therapeutics Announces September 2021 Investor Conference Schedule
-
INOVIO to Present at Upcoming Investor Conferences in September
-
iTeos Therapeutics to Participate in Upcoming September Investor Conferences
-
Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021
-
iTeos Therapeutics to Participate in Upcoming September Investor Conferences
-
Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021
-
New UK Independent Power Producer Created with Investment from EIG
-
Hexo Corp. (HEXO:CN) (HEXO) PT Raised to Cdn$3.45 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Redhill Biopharma (RDHL) at Overweight
-
The Flowr Corporation Announces Second Quarter and First Half 2021 Results
-
Cascadia Acquisition Corp. Announces Closing of $150 Million Initial Public Offering
-
Adamas to Present at Upcoming September Investor Conferences
-
Sabina Gold and Silver Corp. (SBB:CN) (SGSVF) PT Lowered to Cdn$3 at Cantor Fitzgerald
-
Four-Person Advisor Team Joins UBS in Santa Barbara, CA
-
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
-
I-Mab Announces Upcoming Participation at September Conferences
-
UPDATE: Cantor Fitzgerald Upgrades Columbia Care (CCHWF) to Overweight
-
IPO for SPAC Cascadia Acquisition (CCAI) Opens at $9.87
-
Perpetua Resources Announces Full Exercise of Over-Allotment Option
-
Affimed to Present at Upcoming Investor Conferences
-
Affimed to Present at Upcoming Investor Conferences
-
Cascadia Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer Therapies
-
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer Therapies
-
Form SC 13G NAVIENT CORP Filed by: Cantor Fitzgerald Europe
-
HEXO Corp. Closes US$144.8 Million Underwritten Public Offering
-
HEXO Corp. Closes US$144.8 Million Underwritten Public Offering
-
UPDATE: Cantor Fitzgerald Starts Rani Therapeutics Holdsing s (RANI) at Overweight
-
Hexo Corp. (HEXO:CN) (HEXO) PT Lowered to Cdn$3.40 at Cantor Fitzgerald
-
Fury Gold Mines Limited (FURY:CN) (FURY) PT Lowered to $1.80 at Cantor Fitzgerald
-
HEXO Corp. (HEXO) Prices $140 Million Public Offering of Common Stock, Warrants
-
HEXO Corp. Announces US$140 Million Public Offering
-
HEXO Corp. Announces US$140 Million Public Offering
-
HEXO Corp. (HEXO) Announces Proposed Public Offering
-
HEXO Corp. Announces Proposed Public Offering
-
HEXO Corp. Announces Proposed Public Offering
-
Orchid Island Capital Announces August 2021 Monthly Dividend and July 31, 2021 RMBS Portfolio Characteristics
-
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
-
Companies with NDRs 8/18


